Expertise in
28
conditions

Adam R. Witkowski

Alpejska 42 Street, 
Warsaw, MZ, PL 
Expertise in
28
conditions
Alpejska 42 Street, 
Warsaw, MZ, PL 

Overview

Adam Witkowski practices practicing medicine in Warsaw, Poland.

Mr. Witkowski is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Fibromuscular Dysplasia (FMD), Coronary Heart Disease, Heart Attack, Percutaneous Coronary Intervention (PCI), and Transcatheter Aortic Valve Replacement (TAVR).

He is actively involved in clinical research, co-authoring 452 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Alpejska 42 Street, Warsaw, MZ 04628, Poland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Regeneration of Ischemic Damages in Cardiovascular System Using Wharton's Jelly as an Unlimited Source of Mesenchymal Stem Cells for Regenerative Medicine. Project of the National Centre for Research and Development (Poland) 'STRATEGMED II'. Randomized Clinical Trial to Evaluate the Regenerative Capacity of CardioCell in Patients With Chronic Ischaemic Heart Failure (CIHF)
Regeneration of Ischemic Damages in Cardiovascular System Using Wharton's Jelly as an Unlimited Source of Mesenchymal Stem Cells for Regenerative Medicine. Project of the National Centre for Research and Development (Poland) 'STRATEGMED II'. Randomized Clinical Trial to Evaluate the Regenerative Capacity of CardioCell in Patients With Chronic Ischaemic Heart Failure (CIHF)
Enrollment Status: Completed
Publish Date: April 09, 2021
Intervention Type: Drug
Study Phase: Phase 2/Phase 3

452 Total Publications

One-Year Outcomes of M-TEER With the PASCAL System in Atrial and Ventricular FMR: Insights From the MiCLASP Postmarket Clinical Follow-Up Study.
One-Year Outcomes of M-TEER With the PASCAL System in Atrial and Ventricular FMR: Insights From the MiCLASP Postmarket Clinical Follow-Up Study.
Journal: Circulation. Cardiovascular interventions
Published: August 25, 2026

Frequently Asked Questions about Adam R. Witkowski

Is Adam R. Witkowski a top-rated expert for Fibromuscular Dysplasia (FMD)?

MediFind is an objective health platform that identifies experts based on real-world data. Adam R. Witkowski is classified as an Distinguished expert for Fibromuscular Dysplasia (FMD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Adam R. Witkowski participate in research or clinical trials?

Yes. Adam R. Witkowski has published 452 articles and abstracts on conditions like Fibromuscular Dysplasia (FMD). You can view a list of Adam R. Witkowski's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Witkowski's expertise for a condition
ConditionClose
    View All 13 Distinguished Conditions
    View All 15 Advanced Conditions
    View All 34 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile